Peter is CEO of Emmes, a global full-service CRO operating in 30+ countries across ophthalmology, vaccines, rare disease, cell & gene therapy, and neuroscience. He oversees strategy and operations while advising boards, investors, and biotech leaders. Previously, he served as Head of Global Development at Janssen R&D, managing a 10,000+ person team and $2B+ budget, delivering over 450 studies across all phases. He championed innovations in trial design, virtualization, digital health, and diversity. Earlier, Peter held senior roles at Bristol Myers Squibb in Clinical and R&D Operations, and served on the TransCelerate Biopharma Board. He began his career at Accenture and holds a degree from Nottingham University.